Get the Stockscreener App
0.44
4.76%
+0.02
Panbela Therapeutics Inc stock is currently priced at $0.44, with a 24-hour trading volume of 25,779.
It has seen a +4.76% increased in the last 24 hours and a -43.34% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.4365 pivot point. If it approaches the $0.473 resistance level, significant changes may occur.
Previous Close:
$0.42
Open:
$0.48
24h Volume:
25,779
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-23.51M
P/E Ratio:
-0.000978
EPS:
-449.85
Net Cash Flow:
$-27.17M
1W Performance:
+0.08%
1M Performance:
-43.34%
6M Performance:
-49.35%
1Y Performance:
+30.59%
1D Range:
$0.4066
$0.48
52W Range:
$0.40
$0.4895
Panbela Therapeutics Inc Stock (PBLA) Company Profile
Name
Panbela Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Panbela Therapeutics Inc Stock (PBLA) Latest News
Panbela Announces Transfer to OTCQB Market
GlobeNewswire Inc.
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Benzinga
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
GlobeNewswire Inc.
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Dow Edges Lower; Cardlytics Shares Jump
Benzinga
Panbela Therapeutics Inc Stock (PBLA) Financials Data
Panbela Therapeutics Inc (PBLA) Net Income 2024
PBLA net income (TTM) was -$23.51 million for the quarter ending September 30, 2023, a +30.31% increase year-over-year.
Panbela Therapeutics Inc (PBLA) Cash Flow 2024
PBLA recorded a free cash flow (TTM) of -$27.17 million for the quarter ending September 30, 2023, a -106.46% decrease year-over-year.
Panbela Therapeutics Inc (PBLA) Earnings per Share 2024
PBLA earnings per share (TTM) was -$4,010.80 for the quarter ending September 30, 2023, a +90.79% growth year-over-year.
9.90%
3.08%
Cap:
|
Volume (24h):